Literature DB >> 2082160

Cloning of Clostridium difficile toxin B gene and demonstration of high N-terminal homology between toxin A and B.

C von Eichel-Streiber1, R Laufenberg-Feldmann, S Sartingen, J Schulze, M Sauerborn.   

Abstract

High titered Clostridium sordellii lethal toxin antiserum, cross-reactive with C. difficile cytotoxin B (ToxB), was used to isolate toxB fragments from a C. difficile expression library. Recombinant clones containing toxB fragments of the 5' and 3' end were isolate. A 2.5-kb HincII fragment of chromosomal DNA overlaps both groups of clones. A partial restriction map of the total toxB gene is presented. The gene is positioned upstream of utxA and toxA, toxB has a size of 6.9 kb, corresponding to a 250-kDa polypeptide. A partial sequence of the 5' end of toxB was determined. The sequence contains 398 bp upstream of toxB with a putative Shine-Dalgarno box (AGGAGA) and 609 bp of the toxB open reading frame. The N-terminal 203 amino acids of ToxB were compared with the N-terminal amino acids of the enterotoxin A (ToxA). A homology of 64% of the residues was detected, which proves the relatedness of ToxA and ToxB of C. difficile.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2082160     DOI: 10.1007/BF00192465

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   3.402


  14 in total

1.  Nucleotide sequence of Clostridium difficile toxin A.

Authors:  M Sauerborn; C von Eichel-Streiber
Journal:  Nucleic Acids Res       Date:  1990-03-25       Impact factor: 16.971

2.  Purification of two high molecular weight toxins of Clostridium difficile which are antigenically related.

Authors:  C von Eichel-Streiber; U Harperath; D Bosse; U Hadding
Journal:  Microb Pathog       Date:  1987-05       Impact factor: 3.738

Review 3.  Bacterial toxins: a table of lethal amounts.

Authors:  D M Gill
Journal:  Microbiol Rev       Date:  1982-03

4.  Antibiotic-associated pseudomembranous colitis due to toxin-producing clostridia.

Authors:  J G Bartlett; T W Chang; M Gurwith; S L Gorbach; A B Onderdonk
Journal:  N Engl J Med       Date:  1978-03-09       Impact factor: 91.245

5.  DNA sequence analysis with a modified bacteriophage T7 DNA polymerase.

Authors:  S Tabor; C C Richardson
Journal:  Proc Natl Acad Sci U S A       Date:  1987-07       Impact factor: 11.205

6.  Neutralization of Clostridium difficile toxin by Clostridium sordellii antitoxins.

Authors:  T W Chang; S L Gorbach; J B Bartlett
Journal:  Infect Immun       Date:  1978-11       Impact factor: 3.441

7.  Immunochemical and structural similarities in toxin A and toxin B of Clostridium difficile shown by binding to monoclonal antibodies.

Authors:  S W Rothman; M K Gentry; J E Brown; D A Foret; M J Stone; M P Strickler
Journal:  Toxicon       Date:  1988       Impact factor: 3.033

8.  Clostridium difficile toxins A and B inhibit human immune response in vitro.

Authors:  W Däubener; E Leiser; C von Eichel-Streiber; U Hadding
Journal:  Infect Immun       Date:  1988-05       Impact factor: 3.441

9.  Purification and characterization of toxin B from Clostridium difficile.

Authors:  J Meador; R K Tweten
Journal:  Infect Immun       Date:  1988-07       Impact factor: 3.441

10.  Purification and characterization of Clostridium sordellii lethal toxin and cross-reactivity with Clostridium difficile cytotoxin.

Authors:  M R Popoff
Journal:  Infect Immun       Date:  1987-01       Impact factor: 3.441

View more
  12 in total

1.  p38 MAP kinase activation by Clostridium difficile toxin A mediates monocyte necrosis, IL-8 production, and enteritis.

Authors:  M Warny; A C Keates; S Keates; I Castagliuolo; J K Zacks; S Aboudola; A Qamar; C Pothoulakis; J T LaMont; C P Kelly
Journal:  J Clin Invest       Date:  2000-04       Impact factor: 14.808

2.  Monoclonal antibodies specific for Clostridium difficile toxin B and their use in immunoassays.

Authors:  F Müller; C Stiegler; U Hadding
Journal:  J Clin Microbiol       Date:  1992-06       Impact factor: 5.948

Review 3.  Clostridium difficile toxins: mechanism of action and role in disease.

Authors:  Daniel E Voth; Jimmy D Ballard
Journal:  Clin Microbiol Rev       Date:  2005-04       Impact factor: 26.132

4.  Comparative sequence analysis of the Clostridium difficile toxins A and B.

Authors:  C von Eichel-Streiber; R Laufenberg-Feldmann; S Sartingen; J Schulze; M Sauerborn
Journal:  Mol Gen Genet       Date:  1992-05

5.  Intravenous immunoglobulin therapy for severe Clostridium difficile colitis.

Authors:  J Salcedo; S Keates; C Pothoulakis; M Warny; I Castagliuolo; J T LaMont; C P Kelly
Journal:  Gut       Date:  1997-09       Impact factor: 23.059

6.  Survival of anti-Clostridium difficile bovine immunoglobulin concentrate in the human gastrointestinal tract.

Authors:  C P Kelly; S Chetham; S Keates; E F Bostwick; A M Roush; I Castagliuolo; J T LaMont; C Pothoulakis
Journal:  Antimicrob Agents Chemother       Date:  1997-02       Impact factor: 5.191

7.  Transient expression of RhoA, -B, and -C GTPases in HeLa cells potentiates resistance to Clostridium difficile toxins A and B but not to Clostridium sordellii lethal toxin.

Authors:  M Giry; M R Popoff; C von Eichel-Streiber; P Boquet
Journal:  Infect Immun       Date:  1995-10       Impact factor: 3.441

Review 8.  Clostridium difficile: clinical disease and diagnosis.

Authors:  F C Knoop; M Owens; I C Crocker
Journal:  Clin Microbiol Rev       Date:  1993-07       Impact factor: 26.132

9.  Specific detection of toxigenic strains of Clostridium difficile in stool specimens.

Authors:  P H Gumerlock; Y J Tang; J B Weiss; J Silva
Journal:  J Clin Microbiol       Date:  1993-03       Impact factor: 5.948

10.  gp96 is a human colonocyte plasma membrane binding protein for Clostridium difficile toxin A.

Authors:  Xi Na; Ho Kim; Mary P Moyer; Charalabos Pothoulakis; J Thomas LaMont
Journal:  Infect Immun       Date:  2008-04-14       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.